What are the causes of supraventricular tachycardia (SVT)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 24, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Supraventricular Tachycardia

Supraventricular tachycardia is primarily caused by three fundamental mechanisms: re-entry circuits (most common), abnormal automaticity, and triggered activity, with re-entry accounting for the majority of SVT cases including AVNRT, AVRT, and atrial flutter. 1, 2, 3

Primary Mechanisms

Re-entry (Most Common)

  • Re-entry involves repetitive electrical impulse conduction around a fixed obstacle in a defined circuit, requiring unidirectional conduction block in one limb and slow conduction for both initiation and maintenance. 1, 2, 3
  • This mechanism underlies AVNRT (atrioventricular nodal reentrant tachycardia), AVRT (atrioventricular reciprocating tachycardia), and atrial flutter. 1, 2
  • Initiation occurs when a premature impulse encounters the refractory period of one pathway, forcing conduction down an alternative route. 1

Abnormal Automaticity

  • Enhanced diastolic phase 4 depolarization in atrial, AV junctional, or atrial vessel tissues leads to increased firing rates compared to normal pacemaker cells. 2, 3
  • This mechanism causes certain atrial tachycardias and nonparoxysmal junctional tachycardia. 2

Triggered Activity

  • Disturbances in repolarization where afterdepolarizations reach threshold and trigger early action potentials during repolarization. 2, 3
  • This mechanism can contribute to certain forms of atrial tachycardia. 2

Specific SVT Types and Their Causes

AVNRT (Atrioventricular Nodal Reentrant Tachycardia)

  • Caused by a re-entry circuit within the AV node involving dual pathways (fast and slow conducting pathways). 3
  • Most common form of paroxysmal SVT in patients without structural heart disease. 1

AVRT (Atrioventricular Reciprocating Tachycardia)

  • Caused by accessory pathways (bypass tracts) that directly connect atrium and ventricle, bypassing the normal AV node conduction system. 1, 3
  • Manifest accessory pathways (Wolff-Parkinson-White syndrome) occur in 0.1% to 0.3% of the population and conduct anterogradely, showing pre-excitation with delta waves on ECG. 1
  • Concealed pathways conduct only retrogradely and do not cause pre-excitation on standard ECG. 1
  • Orthodromic AVRT accounts for 90-95% of AVRT episodes, using the AV node anterogradely and the accessory pathway retrogradely. 1

Permanent Junctional Reciprocating Tachycardia (PJRT)

  • Rare syndrome involving a slowly conducting, concealed, usually posteroseptal accessory pathway with decremental conduction properties. 1, 2
  • Characterized by incessant SVT with deeply inverted P waves in leads II, III, and aVF, and long RP interval (RP > PR). 1, 2
  • The incessant nature frequently leads to tachycardia-induced cardiomyopathy. 1

Atrial Tachycardia

  • Can be caused by enhanced automaticity, triggered activity, or micro-reentry within atrial tissue. 2, 3
  • Multifocal atrial tachycardia (MAT) is most commonly encountered in patients with chronic pulmonary disease. 1, 2

Atrial Flutter

  • Macro-reentrant circuit typically around the tricuspid annulus. 2, 3
  • Often associated with structural heart disease or acute precipitating events. 2

Nonparoxysmal Junctional Tachycardia

  • Narrow complex tachycardia with rates of 70-120 bpm showing "warm-up" and "cool-down" patterns. 2
  • Specific causes include digitalis toxicity (most important reversible cause), postcardiac surgery, hypokalemia, myocardial ischemia, chronic obstructive lung disease with hypoxia, and inflammatory myocarditis. 2

Predisposing Factors and Associated Conditions

Structural Heart Disease

  • Heart failure, hypertension, valvular disease (especially aortic stenosis), and hypertrophic cardiomyopathy predispose to SVT. 1, 2, 3
  • Structural abnormalities may lead to syncope during SVT episodes. 1

Congenital Heart Disease

  • Ebstein anomaly, Tetralogy of Fallot, transposition of great arteries, and atrial septal defects carry a 10-20% incidence of SVT in adults with congenital heart disease. 2, 3
  • Risk results from surgical scarring, ongoing hemodynamic abnormalities, residual lesions, or decreased ventricular function. 1

Acute Precipitating Events

  • Major surgery, pneumonia, acute myocardial infarction, infection, and volume loss can trigger SVT. 1, 2, 3
  • Fever can trigger cardiac events in patients with Brugada syndrome. 1

Metabolic and Endocrine Disorders

  • Hyperthyroidism and electrolyte abnormalities (particularly hypokalemia) can precipitate SVT. 2, 3

Medications and Substances

  • Digitalis toxicity is the most important reversible cause of nonparoxysmal junctional tachycardia. 2
  • Stimulants, antiarrhythmics, and caffeine can trigger SVT. 2, 3

Critical High-Risk Scenarios

Wolff-Parkinson-White Syndrome with Atrial Fibrillation

  • Rapid anterograde accessory pathway conduction during atrial fibrillation can result in ventricular fibrillation and sudden cardiac death, with a 10-year risk documented in patients with manifest accessory pathways. 1
  • This represents the most dangerous complication of accessory pathway-mediated SVT. 1

Tachycardia-Mediated Cardiomyopathy

  • Persistent SVT for weeks to months with fast ventricular response leads to tachycardia-mediated cardiomyopathy. 1, 2
  • This complication usually resolves after successful treatment of the underlying arrhythmia. 1

Important Clinical Pitfalls

  • Never miss digitalis toxicity as a cause of junctional tachycardia—this is the most important reversible etiology requiring immediate drug withdrawal and consideration of digitalis-binding agents. 2
  • Always evaluate for pre-excitation on baseline ECG, as patients with accessory pathways who develop atrial fibrillation require immediate electrophysiological evaluation due to sudden death risk. 2, 3
  • Do not attribute SVT symptoms solely to anxiety or panic—54% of SVT patients have had their symptoms incorrectly dismissed as psychiatric. 4
  • Most SVT occurs in structurally normal hearts in younger individuals, but always seek associated heart disease with echocardiography, particularly in persistent cases. 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Causes and Management of Persistent Supraventricular Tachycardia (SVT)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Etiologies and Mechanisms of Supraventricular Tachycardia (SVT)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Chest Pain in Supraventricular Tachycardia Episodes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.